Key facts
- It has raised $7.9M; the latest was Accelerator/Incubator in Aug 2025.
- Notable investors include Mana Ventures, SOSV, Gaingels, Liquid 2 Ventures, Realm Capital Ventures — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Vivid Vision
- ·The full record, as it builds
Funding rounds
No funding rounds for Vivid Vision are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vivid Vision
Developer of a virtual reality system designed to treat vision disorders, including lazy eye and crossed eyes. The company's virtual reality system measures eye muscle imbalance to send different images to two eyes accordingly in order to assess binocular vision and treat amblyopia, enabling ophthalmologists to have absolute control and treat patients suffering from strabismus and convergence disorders effectively.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2013
- Employees
- 46
- Website
- seevividly.com/
- Ownership
- Privately Held (backing)
Vivid Vision doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vivid Vision shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vivid Vision in its N-PORT filings yet. We sweep new filings monthly.